Publications by authors named "Sandra Navarra"

Claim this Profile
L
Long-term Safety and Efficacy of Voclosporin in Asian Patients with Lupus Nephritis: A Post Hoc Analysis of the AURORA 2 trial.
Tatsuya Atsumi, Sandra Navarra, Matt Truman, Eisuke Nakata, Haruka Matsukawa

Mod Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort study.
Rangi Kandane-Rathnayake, Alberta Hoi, Worawit Louthrenoo, Vera Golder, Yi-Hsing Chen, Sandra Navarra

Lupus Sci Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of damage accrual by organ domain in systemic lupus erythematosus.
Rangi Kandane-Rathnayake, Luigi Zolio, JIyoon Choi, Vera Golder, Worawit Louthrenoo, Sandra V Navarra

Rheumatology (Oxford)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically Active.
Yanjie Hao, Dylan Hansen, Rangi Kandane-Rathnayake, Worawit Louthrenoo, Yi-Hsing Chen, Sandra Navarra

Arthritis Care Res (Hoboken)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informing trial measurement in systemic lupus erythematosus: frequency of domain-specific disease activity in a multinational cohort.
Raychel Barallon, Kathryn Connelly, Vera Golder, Worawit Louthrenoo, Yi-Hsing Chen, Sandra Navarra

Lupus Sci Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort.
Rangi Kandane-Rathnayake, Worawit Louthrenoo, C S Lau, Laniyati Hamijoyo, Jiacai Cho, Sandra Navarra

Arthritis Res Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set.
Wils Nielsen, Fadi Kharouf, Carolina Munoz Grajales, Aarabi Thayaparan, Melanie Anderson, Sandra Navarra

Semin Arthritis Rheum· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort study.
Rangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Sandra V Navarra

Rheumatology (Oxford)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A charter to improve care for systemic lupus erythematosus.
Marta Mosca, Jeanette Andersen, Patrick Wildman, Susan Manzi, Zahir Amoura, Sandra Navarra

Clin Exp Rheumatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus Cohort.
Yanjie Hao, Dylan Hansen, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Sandra Navarra

ACR Open Rheumatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time trends of variability in disease activity in systemic lupus erythematosus.
Ning Li, Alberta Hoi, Shue-Fen Luo, Yeong-Jian Jan Wu, Worawit Louthrenoo, Sandra Navarra

Lupus Sci Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part A of the LILAC study of litifilimab for systemic lupus erythematosus: a plain language summary.
Richard A Furie, Ronald F van Vollenhoven, Kenneth Kalunian, Sandra Navarra, Juanita Romero-Diaz

Immunotherapy· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part B of the LILAC study of litifilimab for cutaneous lupus erythematosus: a plain language summary.
Victoria P Werth, Richard A Furie, Juanita Romero-Diaz, Sandra Navarra, Kenneth Kalunian

Immunotherapy· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial.
Anca D Askanase, David D'Cruz, Kenneth Kalunian, Joan T Merrill, Sandra V Navarra

Lancet Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2024 APLAR Consensus on the Management of Lupus Nephritis.
Chi Chiu Mok, Ho So, Laniyati Hamijoyo, Nuntana Kasitanon, Der Yuan Chen, Sandra Navarra

Int J Rheum Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Executive Summary of the 2024 Asia-Pacific League of Associations for Rheumatology Consensus Statements on Lupus Nephritis Management.
Desmond Yat Hin Yap, Ho So, Laniyati Hamijoyo, Nuntana Kasitanon, Der Yuan Chen, Sandra Navarra

Int J Rheum Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal associations of flare and damage accrual in patients with systemic lupus erythematosus.
Rangi Kandane-Rathnayake, Dominique Milea, Worawit Louthrenoo, Alberta Hoi, Vera Golder, Sandra Navarra

Lupus Sci Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OMERACT systemic lupus erythematosus domain survey.
Wils Nielsen, Vibeke Strand, Lee Simon, Ellie Pinsker, Dennisse Bonilla, Sandra Navarra

Semin Arthritis Rheum· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus.
Yanjie Hao, Dylan Hansen, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Sandra Navarra

Lupus Sci Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus.
Vera Golder, Rangi Kandane-Rathnayake, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Sandra V Navarra

J Rheumatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study.
Vera Golder, Rangi Kandane-Rathnayake, Ning Li, Worawit Louthrenoo, Yi-Hsing Chen, Sandra V Navarra

Lancet Rheumatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study.
Yasuhiro Katsumata, Eisuke Inoue, Masayoshi Harigai, Jiacai Cho, Worawit Louthrenoo, Sandra Navarra

Ann Rheum Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.
Ricardo Azêdo de Luca Montes, Molla Huq, Timothy Godfrey, Shereen Oon, Alicia Calderone, Sandra V Navarra

Adv Rheumatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set.
Wils Nielsen, Vibeke Strand, Lee S Simon, Ioannis Parodis, Alfred H J Kim, Sandra Navarra

Semin Arthritis Rheum· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases.
Karen Schreiber, Ian Giles, Nathalie Costedoat-Chalumeau, Catherine Nelson-Piercy, Radboud Jem Dolhain, Sandra Navarra

Lancet Rheumatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis